Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Harvard Business School
Moodys
Johnson and Johnson
Medtronic

Last Updated: June 29, 2022

CLINICAL TRIALS PROFILE FOR SUBLOCADE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Sublocade

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03604159 ↗ XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept Completed NYC Health + Hospitals Phase 4 2019-06-24 This is a pilot proof-of-concept randomized controlled trial, open-label and unblinded, examining the feasibility and acceptability of Buprenorphine extended-release vs. daily sublingual buprenorphine-naloxone for the treatment of opioid use disorder in jail and at community re-entry.
NCT03604159 ↗ XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept Completed New York University School of Medicine Phase 4 2019-06-24 This is a pilot proof-of-concept randomized controlled trial, open-label and unblinded, examining the feasibility and acceptability of Buprenorphine extended-release vs. daily sublingual buprenorphine-naloxone for the treatment of opioid use disorder in jail and at community re-entry.
NCT03604159 ↗ XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept Completed NYU Langone Health Phase 4 2019-06-24 This is a pilot proof-of-concept randomized controlled trial, open-label and unblinded, examining the feasibility and acceptability of Buprenorphine extended-release vs. daily sublingual buprenorphine-naloxone for the treatment of opioid use disorder in jail and at community re-entry.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sublocade

Condition Name

Condition Name for Sublocade
Intervention Trials
Opioid-use Disorder 4
Opioid Use Disorder 3
Opioid Dependence 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sublocade
Intervention Trials
Opioid-Related Disorders 11
Substance-Related Disorders 4
Disease 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sublocade

Trials by Country

Trials by Country for Sublocade
Location Trials
United States 10
Australia 4
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sublocade
Location Trials
New Jersey 3
New York 3
Virginia 2
Maryland 1
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sublocade

Clinical Trial Phase

Clinical Trial Phase for Sublocade
Clinical Trial Phase Trials
Phase 4 5
Phase 3 3
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sublocade
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 2
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sublocade

Sponsor Name

Sponsor Name for Sublocade
Sponsor Trials
Indivior Inc. 5
Virginia Commonwealth University 2
New York State Psychiatric Institute 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sublocade
Sponsor Trials
Other 12
Industry 5
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Dow
Johnson and Johnson
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.